4174 related articles for article (PubMed ID: 6219841)
21. Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15.
Takahashi T; Chapman PB; Yang SY; Hara I; Vijayasaradhi S; Houghton AN
J Immunol; 1995 Jan; 154(2):772-9. PubMed ID: 7814883
[TBL] [Abstract][Full Text] [Related]
22. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.
Scheynius A; Klareskog L; Forsum U
Clin Exp Immunol; 1982 Aug; 49(2):325-30. PubMed ID: 6751638
[TBL] [Abstract][Full Text] [Related]
23. Granuloma annulare. Identification of cells in the cutaneous infiltrate by immunoperoxidase techniques.
Modlin RL; Vaccaro SA; Gottlieb B; Gebhard JF; Linden CE; Forni M; Meyer PR; Taylor CR; Rea TH
Arch Pathol Lab Med; 1984 May; 108(5):379-82. PubMed ID: 6370193
[TBL] [Abstract][Full Text] [Related]
24. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.
Jansson R; Karlsson A; Forsum U
Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution.
Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F
Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727
[TBL] [Abstract][Full Text] [Related]
26. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
Engleman EG; Benike CJ; Grumet FC; Evans RL
J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
[TBL] [Abstract][Full Text] [Related]
27. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
[TBL] [Abstract][Full Text] [Related]
28. Identification of normal and transformed lymphocyte subsets of nonhuman primates with monoclonal antibodies to human lymphocytes.
Neubauer RH; Briggs CJ; Noer KB; Rabin H
J Immunol; 1983 Mar; 130(3):1323-9. PubMed ID: 6296233
[TBL] [Abstract][Full Text] [Related]
29. TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas.
Lyle S; Salhany KE; Elder DE
Mod Pathol; 2000 Jan; 13(1):52-5. PubMed ID: 10658910
[TBL] [Abstract][Full Text] [Related]
30. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic T cells directed against HLA-DR antigens and their surface proteins.
Burakoff SJ; Clayberger C; Hemler M; Krensky AM; Reiss CS; Robbins E; Sanchez-Madrid F; Springer TA; Strominger JL; Ware CF
Diagn Immunol; 1983; 1(3):116-9. PubMed ID: 6238749
[TBL] [Abstract][Full Text] [Related]
32. In situ subpopulations of lymphocytes in human colorectal carcinomas.
Lennard TW; Warford A; Taylor RM; Shenton BK; Proud G
Invasion Metastasis; 1984; 4 Suppl 1():60-6. PubMed ID: 6241931
[TBL] [Abstract][Full Text] [Related]
33. OKT4+ cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 molecules.
Strassman G; Bach FH
J Immunol; 1984 Oct; 133(4):1705-9. PubMed ID: 6332131
[TBL] [Abstract][Full Text] [Related]
34. An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies.
Duke O; Panayi GS; Janossy G; Poulter LW
Clin Exp Immunol; 1982 Jul; 49(1):22-30. PubMed ID: 6751631
[TBL] [Abstract][Full Text] [Related]
35. Association of HLA class I and class II antigen expression and mortality in uveal melanoma.
Ericsson C; Seregard S; Bartolazzi A; Levitskaya E; Ferrone S; Kiessling R; Larsson O
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2153-6. PubMed ID: 11527924
[TBL] [Abstract][Full Text] [Related]
36. Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
Carlsson B; Sadeghi A; Bengtsson M; Wagenius G; Tötterman TH
J Immunother; 2008 Sep; 31(7):633-43. PubMed ID: 18600181
[TBL] [Abstract][Full Text] [Related]
37. [Expression of HLA-Dr and CD1+ cells in malignant and benign pigmentary tumors].
Ramírez-Bosca A; Valcuende-Cavero F; Rufat-Pérez MJ; Castells-Rodellas A
Med Cutan Ibero Lat Am; 1989; 17(1):58-64. PubMed ID: 2474114
[TBL] [Abstract][Full Text] [Related]
38. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
[TBL] [Abstract][Full Text] [Related]
39. T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens.
Selby WS; Janossy G; Goldstein G; Jewell DP
Clin Exp Immunol; 1981 Jun; 44(3):453-8. PubMed ID: 6459893
[TBL] [Abstract][Full Text] [Related]
40. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
